Impact of offsetting midyear list price and rebate reductions in Medicare Part D
By Matthew Hayes and David R. Mike
05 April 2019
The structure of the Medicare Part D program produces interesting, and sometimes counterintuitive, financial outcomes when drug list prices are decreased and rebates are eliminated. This paper analyzes the impact of mid-year drug list price reductions coupled with a reduction in rebates resulting in identical net price.
About the Author(s)
David R. Mike
Impact of offsetting midyear list price and rebate reductions in Medicare Part D
The structure of the Medicare Part D program produces interesting, and sometimes counterintuitive, financial outcomes when drug list prices are decreased and rebates are eliminated.
Matthew Hayes, David Mike